Updated Aug. 17, 2012 at 6:36 a.m.

Premium Lock GSK experimental asthma drug cuts attacks nearly 50%

Published: 2012-08-16 19:16:00
Updated: 2012-08-17 06:36:21

GSK  GSK

Among 621 participants with severe asthma, after a year of treatment, the rate of attacks requiring oral corticosteroids, emergency room visits or hospitalizations was about half for those taking one of three monthly doses of the drug, called mepolizumab, compared with those on placebo, study finds....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

page 1
sort order: oldest first | newest first
Wow, do you even know how to comprehend that all drug studies are usually funded by the company developing the drug and that journals, such as the Lancet, are the ones who publish the results after their review?
There will be forthcoming bribe money for the FDA
according to GSK
page 1
sort order: oldest first | newest first

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll